|
|
2140 North Miami Avenue
Miami
FL
33127
United States
800-327-4565
|
|
Private
|
Diamedix Corporation and its forerunner, Cordis Laboratories, have been on the leading edge of medical diagnostic technologies for more than a quarter century. Throughout the years, Diamedix has continued to pioneer unique immunodiagnostic innovations in its products, procedures, and in the development of integrated instrument and reagent systems for both autoimmune and infectious disease detection. Today, Diamedix maintains its tradition of developing product systems designed specifically to simplify and improve diagnostic testing in ways that enhance efficiency and accuracy, while promoting economy.
Diamedix is a subsidiary of IVAX Diagnostics, Inc., which is a public company traded on the American Stock Exchange under the symbol IVD. IVAX Diagnostics is 72 owned by Teva Pharmaceutical Industries Ltd., following their merger with IVAX Corporation on January 26, 2006. Teva is headquartered in Israel and is among the top 20 pharmaceutical companies in the world and is the leading generic pharmaceutical company.
IVAX Diagnostics consists of Diamedix and its sister companies, Delta Biologicals S.r.l. and ImmunoVision, Inc. Our affiliation with these companies has allowed us to further strengthen our commitment to quality medical diagnostic technologies.
|
|
|
|
|
http://www.diamedix.com/
|
|
|
|
|
|
|
|
|
|
Is® ENA-6 Screen Product Literature
The Diamedix Immunosimplicity® Is-ENA-6 Screen Test Kit is an EIA procedure intended for the detection of IgG antibodies to six ENAs. Positive samples can be further evaluated using specific ENA test kits.
read more...
|
|
|
|
|
|
|